Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Busch

Transfusion

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Transfusion|February 1, 1997
To thy (reactive) donors be true!M P Busch
Transfusion|September 1, 1991
Let's look at human immunodeficiency virus look-back before leaping into hepatitis C virus look-backM P Busch
Transfusion|November 1, 1992
Idiopathic CD4+ T-lymphocytopenia (ICL) and the safety of blood transfusions: what do we know and what should we do?M P Busch, P V Holland
Transfusion|November 3, 2000
NAT and blood safety: what is the paradigm?M P Busch, R Y Dodd
Transfusion|March 1, 1997
Relative sensitivity of United States and European assays for screening blood donors for antibodies to human immunodeficiency virusesM P Busch, A M Couroucé
Transfusion|September 12, 2001
HBV: amplified and back in the blood safety spotlightS H Kleinman, M P Busch
Transfusion|July 1, 1995
Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost?M P Busch, H J Alter
Transfusion|November 1, 1991
Confidential unit exclusion: how should it be evaluated?L R Petersen, M P Busch
Transfusion|March 1, 1993
Performance of hepatitis C virus (HCV) second-generation enzyme immunoassay (EIA) on blood samples that reacted in the first-generation HCV EIAL Tobler, S R Lee, M P Busch
Transfusion|November 1, 1988
How well has self-exclusion worked?H A Perkins, S Samson, M P Busch
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Transfusion|February 1, 1997
To thy (reactive) donors be true!M P Busch
Transfusion|September 1, 1991
Let's look at human immunodeficiency virus look-back before leaping into hepatitis C virus look-backM P Busch
Transfusion|November 1, 1992
Idiopathic CD4+ T-lymphocytopenia (ICL) and the safety of blood transfusions: what do we know and what should we do?M P Busch, P V Holland
Transfusion|November 3, 2000
NAT and blood safety: what is the paradigm?M P Busch, R Y Dodd
Transfusion|March 1, 1997
Relative sensitivity of United States and European assays for screening blood donors for antibodies to human immunodeficiency virusesM P Busch, A M Couroucé
Transfusion|September 12, 2001
HBV: amplified and back in the blood safety spotlightS H Kleinman, M P Busch
Transfusion|July 1, 1995
Will human immunodeficiency virus p24 antigen screening increase the safety of the blood supply and, if so, at what cost?M P Busch, H J Alter
Transfusion|November 1, 1991
Confidential unit exclusion: how should it be evaluated?L R Petersen, M P Busch
Transfusion|March 1, 1993
Performance of hepatitis C virus (HCV) second-generation enzyme immunoassay (EIA) on blood samples that reacted in the first-generation HCV EIAL Tobler, S R Lee, M P Busch
Transfusion|November 1, 1988
How well has self-exclusion worked?H A Perkins, S Samson, M P Busch
Pageof 9